Shi Zhengzhou, Wang Qi, Jiang Dapeng
Department of Urology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Transl Androl Urol. 2020 Oct;9(5):2071-2081. doi: 10.21037/tau-20-833.
Urethral stricture (US) is a major challenge in urology and there is an urgent need for effective therapies for its treatment. Exosomes derived from bone marrow mesenchymal stem cells (BMSCs-Exos) have been shown to be effective in preventing scar and fibrosis formation after tissue injury. However, the potential utility of BMSCs-Exos in the prevention of US remains unknown. We hypothesized that local administration of BMSCs-Exos may influence urethral healing and scar formation in a rat model of US.
A previously established model of rat US was used in this study. Sprague Dawley rats were randomly assigned into sham, US, and US + BMSCs-Exos groups. Micro-ultrasound assessment, histopathology, immunohistochemistry, and gene expression analysis were performed at four weeks post-surgery.
US rats exhibited thick urethral walls with a narrowed lumen, when compared with sham rats. However, these changes were suppressed in the US + BMSCs-Exos group. The preventative effects of BMSCs-Exos on US formation were also apparent histologically. US + BMSCs-Exos rats demonstrated decreased expression of several fibrosis-related genes in urethral tissues, including Col I, fibronectin, and elastin, when compared with US rats. BMSCs-Exos treatment also led to an increase in the expression of angiogenesis-related genes in these tissues, including VEGF, eNOS, and bFGF.
Our findings therefore demonstrate that the local administration of BMSCs-Exos prevents urethral stricture formation by regulating fibrosis and angiogenesis. These findings provide a basis for an innovative strategy involving the clinical application of exosomes to counteract US formation.
尿道狭窄(US)是泌尿外科的一项重大挑战,迫切需要有效的治疗方法。骨髓间充质干细胞来源的外泌体(BMSCs-Exos)已被证明在预防组织损伤后瘢痕和纤维化形成方面有效。然而,BMSCs-Exos在预防尿道狭窄方面的潜在效用仍不清楚。我们假设在大鼠尿道狭窄模型中局部施用BMSCs-Exos可能会影响尿道愈合和瘢痕形成。
本研究使用先前建立的大鼠尿道狭窄模型。将Sprague Dawley大鼠随机分为假手术组、尿道狭窄组和尿道狭窄+BMSCs-Exos组。在手术后四周进行微超声评估、组织病理学、免疫组织化学和基因表达分析。
与假手术组大鼠相比,尿道狭窄组大鼠尿道壁增厚,管腔狭窄。然而,这些变化在尿道狭窄+BMSCs-Exos组中受到抑制。BMSCs-Exos对尿道狭窄形成的预防作用在组织学上也很明显。与尿道狭窄组大鼠相比,尿道狭窄+BMSCs-Exos组大鼠尿道组织中几种纤维化相关基因的表达降低,包括I型胶原、纤连蛋白和弹性蛋白。BMSCs-Exos治疗还导致这些组织中血管生成相关基因的表达增加,包括血管内皮生长因子(VEGF)、内皮型一氧化氮合酶(eNOS)和碱性成纤维细胞生长因子(bFGF)。
因此,我们的研究结果表明,局部施用BMSCs-Exos可通过调节纤维化和血管生成来预防尿道狭窄形成。这些发现为涉及外泌体临床应用以对抗尿道狭窄形成的创新策略提供了基础。